These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ultrasound determination of the effect of progestogens on the endometrium in postmenopausal women receiving hormone replacement therapy. Meuwissen JH; van Langen H; Navarro I Maturitas; 1994 Feb; 18(2):77-85. PubMed ID: 8177096 [TBL] [Abstract][Full Text] [Related]
4. A modern approach to postmenopausal HRT: trading bleeding with safety. Al-Azzawi F; Wahab M Womens Health (Lond); 2012 Jan; 8(1):1-4. PubMed ID: 22171766 [No Abstract] [Full Text] [Related]
6. Progesterone, progestins and the endometrium in perimenopause and in menopausal hormone therapy. Gompel A Climacteric; 2018 Aug; 21(4):321-325. PubMed ID: 29583028 [TBL] [Abstract][Full Text] [Related]
7. The impact of micronized progesterone on breast cancer risk: a systematic review. Stute P; Wildt L; Neulen J Climacteric; 2018 Apr; 21(2):111-122. PubMed ID: 29384406 [TBL] [Abstract][Full Text] [Related]
8. Endometrial morphology and bleeding patterns as a function of progestogen supplementation. Sturdee DW Int J Fertil Menopausal Stud; 1996; 41(1):22-8. PubMed ID: 8673153 [TBL] [Abstract][Full Text] [Related]
9. The impact of micronized progesterone on the endometrium: a systematic review. Stute P; Neulen J; Wildt L Climacteric; 2016 Aug; 19(4):316-28. PubMed ID: 27277331 [TBL] [Abstract][Full Text] [Related]
11. The uterus and the menopause. Rees MC Baillieres Clin Obstet Gynaecol; 1996 Sep; 10(3):419-32. PubMed ID: 8931903 [TBL] [Abstract][Full Text] [Related]
12. [Changes in endometrial vascularisation due to hormone therapy in menopause]. Russu M; Terzea D; Hudiţă D Rev Med Chir Soc Med Nat Iasi; 2004; 108(2):329-37. PubMed ID: 15688809 [TBL] [Abstract][Full Text] [Related]
14. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016 [TBL] [Abstract][Full Text] [Related]
15. Can the withdrawal bleed following oestrogen replacement therapy be avoided? Leather AT; Studd JW Br J Obstet Gynaecol; 1990 Dec; 97(12):1071-4. PubMed ID: 2279015 [No Abstract] [Full Text] [Related]
16. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Panay N; Studd J Hum Reprod Update; 1997; 3(2):159-71. PubMed ID: 9286739 [TBL] [Abstract][Full Text] [Related]
17. [Estrogen progestogen replacement therapy for hyperlipidemia in postmenopausal women]. Hayakawa A Nihon Rinsho; 2001 Mar; 59 Suppl 3():701-6. PubMed ID: 11347158 [No Abstract] [Full Text] [Related]
18. Progestogens in postmenopausal hormone therapy and the risk of breast cancer. Lambrinoudaki I Maturitas; 2014 Apr; 77(4):311-7. PubMed ID: 24485796 [TBL] [Abstract][Full Text] [Related]
19. Reducing the problems of the progestogen. Sturdee DW; MacLennan AH Climacteric; 2006 Aug; 9(4):241-3. PubMed ID: 16857653 [No Abstract] [Full Text] [Related]
20. [Estrogens, progestins and cancer of the endometrium]. Laffargue F; Daures JP Rev Prat; 1993 Dec; 43(20):2603-9. PubMed ID: 8146558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]